|
⚲
|
| Keyboard |
| Josh Resnick | |
|---|---|
| Firm | |
| Address | c/o Ventus Therapeutics Us, Inc 100 Beaver Street, Suite 202 Walthum, MA 02453 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Ventus Therapeutics US Inc | 021-433406 | Director | 70.0 M of 140.0 M |
||
| Bright Peak Therapeutics Inc | 021-402693 | Director | 106.5 M of 106.5 M |
||
| Ventus Therapeutics US Inc | 021-395752 | Director | 100.0 M of 100.0 M |
||
| Pepgen Inc | 021-382689 | Director | 14.4 M of 51.8 M |
||
| Limber Inc | 021-356766 | Director | 2.2 M of 2.5 M |
||
| Payoffcom Inc | 021-199038 | Director | 7.0 M of 7.0 M |
||
| Costim Pharmaceuticals Inc | 021-194766 | Director | 10.0 M of 22.3 M |
||
| Iscience Interventional Corp | 021-172696 | Director | 2.8 M of 5.0 M |
||
| Iscience Interventional Corp | 021-164648 | Director | 3.0 M of 3.0 M |
||
| Nprogress Inc | 021-163375 | Executive Officer | 1.8 M of 2.0 M |
||
| Iscience Interventional Corp | 021-159929 | Director | 5.3 M of 6.0 M |
||
| Iscience Interventional Corp | 021-146206 | Director | 5.1 M of 10.0 M |
||